Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
Public ClinicalTrials.gov record NCT01475461. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blinded, Placebo-controlled, Dose-ranging, Parallel Group Study To Evaluate Safety And Efficacy Of Pf-04937319 And Sitagliptin On Glycemic Control In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
B1621007 is designed to study the safety and efficacy of PF-04937319 in patients with type 2 diabetes
Study identification
- NCT ID
- NCT01475461
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 345 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- PF-04937319 - 3mg Drug
- PF-04937319 - 20mg Drug
- PF-04937319 - 50mg Drug
- PF-04937319 - 100mg Drug
- Sitagliptin - 100mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2011 (Type not available)
- Primary completion
- Jan 2013 (Actual)
- Completion
- Jan 2013 (Actual)
- Last update posted
- Jan 31, 2017
2011 – 2013
United States locations
- U.S. sites
- 24
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials | Anaheim | California | 92801 | — |
| National Research Institute | Los Angeles | California | 90057 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| The Family Doctors of Belleview | Belleview | Florida | 34420 | — |
| Swiss Medical Research | Miami | Florida | 33135 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Rockdale Medical Research Associates | Conyers | Georgia | 30094 | — |
| Solaris Clinical Research | Meridian | Idaho | 83646 | — |
| Central Kentucky Research Associates, Inc. | Mount Sterling | Kentucky | 40353 | — |
| Mount Sterling Clinic | Mount Sterling | Kentucky | 40353 | — |
| The Office of Dr. Matthew S. Barton, MD | Las Vegas | Nevada | 89144 | — |
| TKL Research, Inc. | Paramus | New Jersey | 07652 | — |
| Rochester Clinical Research, Inc. | Rochester | New York | 14609 | — |
| Lillestol Research, LLC | Fargo | North Dakota | 58103 | — |
| PriMed Clinical Research | Kettering | Ohio | 45429 | — |
| PriMed Physicians | Kettering | Ohio | 45429 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Medical Research South, LLC | Charleston | South Carolina | 29407 | — |
| Newton Family Medicine | Charleston | South Carolina | 29407 | — |
| Austin Center for Clinical Research | Austin | Texas | 78756 | — |
| Texas Center for Drug Development, Inc. | Houston | Texas | 77081 | — |
| Plano Primary Care Clinic | Plano | Texas | 75024 | — |
| Pioneer Research Solutions, Inc. | Sugar Land | Texas | 77479 | — |
| Martin Diagnostic Clinic | Tomball | Texas | 77375 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01475461, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 31, 2017 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01475461 live on ClinicalTrials.gov.